BGI Group’s new facility is the first coronavirus test production facility in Ethiopia that opened earlier this month. It is designed to be able to make 6-8 million tests in a year and can expand the annual capacity to up to 10 million in accordance with local demand. BGI, which makes genome sequencing and medical devices, is hoping to use its footprint in Ethiopia in expanding its supplies to other African countries. The Ethiopia factory could be later converted to make test kits for HIV, malaria and tuberculosis once the Covid-19 pandemic ends. Ethiopia, one of the countries that has the most new daily infections on average in Africa, has reported 69,709 infections and 1,108 coronavirus-related deaths since the pandemic began.
SOURCE: CNN
More Stories
South Africa Still a Long Way Off in Building a National Culture of Human Rights
After Lawsuits and Demonstrations Led by Chagossian Women, Britain Paid Some Compensation through the Mauritian Government to the Exiled Chagos Population
Sister to Egypt’s Most Prominent Political Prisoner Takes the Fight to the UN and EU
MSI Reproductive Choices in Africa Helps Women and Girls Make Informed Decisions about their Bodies and Futures
Kenya’s ‘Linda Mama’ Policy is a Step in the Right Direction Towards Universal Health Coverage
The Women and Caregivers behind Uganda’s Model for Palliative Care
Tunisian President’s Speech was Essentially the “Great Replacement” Theory, but with a Local Twist
The UN’s Largest Annual Gathering on Gender Equality and Women’s Empowerment Tackles the Gender Digital Divide
Challenges And Opportunities – Global Survey Results On Women’s Tech Careers
WHO Director’s Insights on Health in Africa and the IIAG Results
Best Style Moments of Tems
To the World